First Time Loading...

Phreesia Inc
NYSE:PHR

Watchlist Manager
Phreesia Inc Logo
Phreesia Inc
NYSE:PHR
Watchlist
Price: 21.96 USD 0.09% Market Closed
Updated: May 10, 2024

Phreesia Inc
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Phreesia Inc
Cost of Revenue Peer Comparison

Comparables:
VEEV
INSP
EVH
DOCS
GDRX

Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Phreesia Inc
NYSE:PHR
Cost of Revenue
-$124m
CAGR 3-Years
-33%
CAGR 5-Years
-27%
CAGR 10-Years
N/A
Veeva Systems Inc
NYSE:VEEV
Cost of Revenue
-$677.3m
CAGR 3-Years
-18%
CAGR 5-Years
-23%
CAGR 10-Years
-23%
Inspire Medical Systems Inc
NYSE:INSP
Cost of Revenue
-$96.6m
CAGR 3-Years
-76%
CAGR 5-Years
-57%
CAGR 10-Years
N/A
Evolent Health Inc
NYSE:EVH
Cost of Revenue
-$1.5B
CAGR 3-Years
-29%
CAGR 5-Years
-36%
CAGR 10-Years
N/A
Doximity Inc
NYSE:DOCS
Cost of Revenue
-$53.5m
CAGR 3-Years
-53%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Goodrx Holdings Inc
NASDAQ:GDRX
Cost of Revenue
-$66.9m
CAGR 3-Years
-31%
CAGR 5-Years
-62%
CAGR 10-Years
N/A

See Also

What is Phreesia Inc's Cost of Revenue?
Cost of Revenue
-124m USD

Based on the financial report for Jan 31, 2024, Phreesia Inc's Cost of Revenue amounts to -124m USD.

What is Phreesia Inc's Cost of Revenue growth rate?
Cost of Revenue CAGR 5Y
-27%

Over the last year, the Cost of Revenue growth was -13%. The average annual Cost of Revenue growth rates for Phreesia Inc have been -33% over the past three years , -27% over the past five years .